RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
          펼치기
        • 등재정보
          펼치기
        • 학술지명
          펼치기
        • 주제분류
          펼치기
        • 발행연도
          펼치기
        • 작성언어
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        오리엔탈나리의 球根 收穫時期와 低溫處理 期間이 生育에 미치는 影響

        金熙峻,金正萬,金致善,柳汀,崔泳根,文炳永 한국화훼연구회 2001 화훼연구 Vol.9 No.1

        This study was carried out to determine the effect of the duration of chilling treatment and the lifting time of bulbs on growth of Lilium Oriental hybrids for product of cut flower in the type of forcing or semiforcing culture in Korea. "Casablanca", "Acapulco" and "Le Reve" in lilium Oriental hybrids were used in these experiment and carried out from 1999 to 2000 in Iksan, Korea. The bulbs for experiment were lifted on August 27, September 27 and October 27 and the all of them were chilled at 5±1℃ for 0,8,10,12 weeks. Development of the bulbs lifted on October 27 was superior than that of lifted bulbs on August 27 in the three cultivars. The bulbs lilted lately and chilled for a long time were sprouted more earlier and grown faster. In order to increase bulb sprouting until 100%, the duration of chilling treatment of bulbs was need for 12 weeks on August 27, 10 weeks on September 27 and above 8 weeks on October 27. The flowering according to the duration of chilling treatment and the lifting time of bulbs was same above. Consequently, the bulbs should be chilled at 5±1℃ for chilled for 10 weeks at late September and 8 weeks in producted bulbs at late October in earlyㆍMidseason variety fur product of cut flower hut bulbs of late variety should be chilled for 12 weeks at late September and 10 weeks at late October.

      • 간세포암에 대한 간동맥 화학색전술의 치료효과

        이헌영,김병호,정현용,김영건,조준식 충남대학교 의과대학 지역사회의학연구소 1993 충남의대잡지 Vol.20 No.2

        Hepatocellular carcinoma(HCC) is the second most common cause of cancer death in Korea. Generally, HCC was unresectable due to the frequently associated cirrhosis and advanced stage of tumor. As a palliative therapy of HCC, transcatheter arterial chemoembolization(TACE) was a proven effective mean of treating inoperable HCC. We have analyzed the effectiveness of TACE in inoperable HCC. TACE was performed in 20 patients from January in 1990 to May in 1993 at Chung Nam National University Hospital with the infusion of mixture of Lipiodol and Adriamycin. We analyzed the survival rates of the TACE group and the control group who received no specific treatment. The results were follows ; 1) The survival rate was significantly higher in TACE group than control group(p<0.01). The survival rate at the end sixth months and one year were 62.8% and 40.0% in TACE group, 26.6% and 0% in control group, respectively. 2) A declining level of AFP(Alph-fetoprotein) was shown in 8 among 10 cases who underwent TACE/and was higher than 500 ng/ml in pre-TACE level(p<0.01) and also tumor size was decreased in 7 among 20 cases who underwent TACE. 3) Side effects were fever(80.0%), and upper abdominal pain(75.0%) in TACE group but improved within 7 days after TACE and impairment of liver function was developed in most patients(TACE group) but improved within 2 weeks after TACE. As a palliative therapy of HCC, TACE is an effective and useful modality in treating and prolonging the survival time of patients with unresectable hepatocellular carcinoma.

      • KCI등재

        정상 면역 성인에서 발생한 거대세포바이러스 위염 1예

        김갑현,박병배,백현정,이준행,백승운,백경란,장기택 대한내과학회 2004 대한내과학회지 Vol.66 No.3

        거대세포바이러스 감염은 주로 면역기능이 저하된 환자에서 치명적인 기회감염으로 잘 나타나는 질환이다. 한편 면역 상태가 정상인 사람에서 발생되는 경우는 매우 드물다. 저자들은 심와부 동통과 구토를 주소로 내원한 정상면역의 27세 남자 1예를 보고한다. 상부위내시경상위 점막 결절상과 궤양소견을 보였고, 위 점막 결절과 궤양부위 조직검사상 거대세포바이러스 봉입체의 관찰로 거대세포바이러스 위염을 진단하였다. 최근 감염과 일차감염을 나타내는 거대세포바이러스 Ig M 항체는 양성이었다. Ganciclovir와 proton pump 억제제를 병용하여 치료하였고 증상 호전과 거대세포바이러스 seroconversion을 확인하였다. 저자들은 거대세포바이러스가 정상면역 성인에서 위 궤양을 일으킬 수 있는 경우를 경험하여 보고하는 바이다. Cytomegalovirus (CMV) infections are usually reported in immunocompromised patients. However, it occurs rarely in immunocompetent individuals. A case of CMV associated with stomach ulcers and mucosal nodules is reported in a immunocompetent host. A previously healthy 27-year-old man visited our hospital with a thirty-day history of epigastric pain and a nine-day history of vomiting. The demonstration of intranuclear inclusion bodies in a few gastric glandular epithelial cells contributed to the diagnosis of CMV gastritis. Treatment with a proton pump inhibitor and ganciclovir was successful to mitigate the epigastric pain and vomiting.

      • 급성 및 만성 간질환에서 C형 간염바이러스 항체(anti-HCV)양성률

        김삼용,성자원,김병호,이기천,허승식,길준영,정현용,이헌영,김영건 충남대학교 의과대학 지역사회의학연구소 1992 충남의대잡지 Vol.19 No.2

        The prevalence of antibody against hepatitis C virus (anti-HCV) was investigated in 331 patients with various liver diseases from April 1992 to September 1992. The presence of anti-HCV was detected by Lucky HCD EIA test in 331 cases and by (Ortho HCV Antibody ELISA test 148 patients) The results are summarized as follows: 1. Overall, antibody to HCV(anti-HCV) was positive in 37(11%) of 331 patients with various liver diseases. 2. 16(11%) of 144 patients with chronic hepatitis, 2(5%) of 37 patients with alcoholic liver disease, 17(22%) of 76 patients with liver cirrhosis and 2(5%) of 38 HBsAg carriers were positive for anti-HCV.None of 12 patients with acute hepatitis, 11 patients with drug induced hepatitis and 13 patients with hepatocellular carcinoma was anti-HCV positive. 3. HBsAg positivity in patients who had anti-HCV was 24%(9/37). 4. A positive correlation was found between Lucky HCD and Ortho HCV test. Of 128 Lucky HCD negative cases, 124 cases were negative for Ortho HCV ELISA and 4 cases were positive for Ortho HCV ELISA Of 20 Lucky HCD positive cases, 11 cases were positive for Ortho HCV ELISA and 9 cases were negative for Ortho HCV ELISA. These results suggest that hepatitis C virus has an important etiologic role in HBsAg negative chronic hepatitis and liver cirrhosis in Korea. The diagnostic value of Lucky HCD EIA test may be slightly better or equivalent to Ortho HCV ELISA test in the diagnosis of Hepatitis C virus infection.

      • KCI등재

        정신분열병에 대한 리스페리돈의 효과 및 안정성

        이민수,김용구,김영훈,연병길,오병훈,윤도준,윤진상,이철,정희연,강병조,김광수,김동언,김명정,김상훈,김희철,나철,노승호,민경준,박기창,박두병,백기청,백인호,손봉기,손진욱,양병환,양창국,우행원,이정호,이종범,이홍식,임기영,전태연,정영조,정영철,정인과,정인원,지익성,채정호,한상익,한선호,한진희,서광윤 大韓神經精神醫學會 1998 신경정신의학 Vol.37 No.1

        연구목적 : 본 시험의 목적은 임상시험 시작전에 연구자들을 대상으로 PANSS Workshop을 통하여 PANSS, ESRS에 대한 국내에서의 표준화 작업을 구축하고 새로운 정신병 치료제인 리스페리돈의 효과와 안정성을 재확인하여 리스페리돈 사용에 대한 적정화를 이루는데 있다. 연구방법 : 1996년 4월부터 1996년 9월까지 국내 39개 대학병원 정신과에 입원중인 혹은 증상이 악화되어 입원하는 정신분열병 환자 377명을 대상으로 다시설 개방 연구를 시행하였다. 1주일간의 약물 배설기간을 가진후, 리스페리돈을 8주간 투여하였고, 기준점, 1주, 2주, 4주, 그리고 8주후에 평가되었다. 용량은 제1일에는 리스페리돈 1mg씩 1일 2회, 제2일에는 2mg씩 1일 2회, 제3∼7일에는 3mg씩 1일 2회 투여하였다. 이후 환자의 임상상태에 따라 임의로 증량할 수 있으며, 최대 일일 16mg을 초과하지 않도록 하였다. 추체외로 증상을 조절하기 위한 투약을 허용하였다. 임상증상 및 부작용의 평가는 PANSS(Positive and Negative Syndrome Scale), CGI(Clinical Global Impression) 그리고 ESRS(Extrapyramidal Symptom Rating Scale)을 사용하였다. 연구결과 : 377명중 343명(91%)이 8주간의 연구를 완결하였다. 치료 종결시점인 8주후 PANSS 총점수가 20% 이상 호전된 경우를 약물 반응군으로 정의할때, 약물반응군은 81.3%였다. 리스페리돈에 반응하는 예측인자로는 발병연령, 이전의 입원 횟수, 유병기간이 관련 있었다. 리스페리돈은 1주후부터 PANSS양성, 음성, 및 일반정신병리 점수상에 유의한 호전을 보여 효과가 빨랐다. CGI의 경우도 기준점에 비해 1주후부터 유의한 감소를 나타내었다. ESRS의 경우, 파킨슨 평가점수는 기준점과 비교해 투여 1주, 2주, 4주후 유의하게 증가되었다가 8주후 기준점과 차이가 없었다. Dystonia 평가점수는 1주후만 유의한 증가를 보였으며, dyskinesia 평가점수는 유의한 차이가 없었다. 혈압, 맥박수의 생명징후 및 일반 혈액학 검사, 생화학적 검사, 심전도 검사에서 유의한 변화는 없었다. 결 론 : 이상의 다시설 개방 임상 연구를 통해 리스페리돈은 정신분열병 환자에서 양성증상뿐만 아니라 음성증상 및 전반적인 증상에도 효과적인 것으로 사료된다. 보다 명확한 평가를 위해서는 다른 항정신병약물과의 이중맹검 연구가 필요할 것으로 생각되며, 또한 장기적 치료에 대한 평가도 함께 이루어져야 하겠다. Objective : The purpose of this study was to investigate the efficacy and safety of risperidone in the treatment of Korean schizophrenic patients. Method : This multicenter open study included 377 schizophrenic patients drawn from 39 university hospitals. After a wash-out period of 1 week, the schizophrenic patients were treated with risperidone for 8 weeks and evaluated at 5 points ; at baseline, and 1, 2, 4 and 8 weeks of treatment. The dose was increased from 2mg/day(1mg twice daily) to 6mg/day(3mg twice daily) during the first week and adjusted to a maximum of 16mg/day over the next 7 weeks according to the patient's clinical response. Medication to control extrapyramidal symptoms was permitted. The psychiatric and neurological status of the patients was assessed by PANSS, CGI, and ESRS scales. Results : 343(91%) of 377 patients completed the 8-week trial period. Clinical improvement, as defined by a 20% or more reduction in total PANSS score at end point, was shown by 81.3% of patients. The predictors of response to risperidone were associated older age, shorter duration of illness, fewer previous hospitalization. Risperidone had rapid onset of action ; a significant decrease of the total PANSS and three PANSS factor(positive, negative, general), and CGI was already noticed at the end of first week. For the ESRS, parkinsonism rating scores were significantly increased until week 4 comparing with baseline. Dystonia rating scores were significantly increased until week 1, and dyskinesia rating scores were not significantly changed during the study. Laboratory parameters including vital sign, EKG, hematological, and biochemical values showed no significant changes during the trial. Conclusions : This study suggests that risperidone is generally safe and effective against both the positive and negative symptoms in our group of patients.

      • KCI등재

        Downscaling Study of Uncooled a-Si Infrared Microbolometer Cell based on Simulation

        Jun-Kyo Jeong,Byeong-Jun Jeong,Jae- Sub Oh,Ga-Won Lee 대한전자공학회 2020 Journal of semiconductor technology and science Vol.20 No.1

        This study analyzes the response time, that is, thermal time constant of an uncooled amorphous silicon (a-Si) infrared (IR) microbolometer cell based on simulation when the device is downscaled for higher resolution. For accurate analysis, an 8080 array of a-Si microbolometer was fabricated with a 35 μm pixel size. The real device was used to extract the external environmental parameter for the simulation where temperature coefficient of resistance (TCR) of a-Si is also modeled to include temperature-dependence. It is known qualitatively that the cell geometries like as the length of the resistance layer and width of the leg are key factors for the time constant of the device. When the pixel is downscaled to 17 μm, the time constant is found to increase as the length of the resistance layer becomes narrower, but this tendency is reversed for the width of the leg. This is because the influence of each component on the total resistance is changed according to the cell area, which is efficiently optimized by the simulation analysis.

      • SCOPUSKCI등재
      • SCOPUSKCI등재

        Pd 코팅 된 중공사형 La<sub>0.1</sub>Sr<sub>0.9</sub>Co<sub>0.2</sub>Fe<sub>0.8</sub>O<sub>3-δ</sub> 촉매의 제조 및 미량 산소 제거 특성 연구

        정병준 ( Byeong Jun Jeong ),이홍주 ( Hong Ju Lee ),김민광 ( Min Kwang Kim ),이승환 ( Seung Hwan Lee ),박정훈 ( Jung Hoon Park ) 한국화학공학회 2019 Korean Chemical Engineering Research(HWAHAK KONGHA Vol.57 No.6

        본 연구에서는 저온에서 매립지 가스(LFG)하에서 메탄의 완전 산화 특성 분석을 위한 고성능 Pd 코팅La<sub>0.1</sub>Sr<sub>0.9</sub>Co<sub>0.2</sub>Fe<sub>0.8</sub>O<sub>3-δ</sub> (LSCF-1928)촉매를 개발하였다. LSCF-1928 촉매를 분말형과 중공사형으로 성형한 후 중공사형의 표면을 무전해도금법으로 Pd를 코팅하였다. 성형된 촉매는 TPR을 통해 촉매에 흡착 된 산소종과 그 흡착 량을 분석하였고, SEM을 통해 중공사형 기공구조를 확인하였으며, XRD를 통해 촉매의 안정성을 확인하였다. 메탄 산화 실험 결과 LSCF-1928 촉매의 메탄 완전산화 온도는 475 oC 이었으나, Pd코팅 된 LSCF-1928 촉매는 이보다 낮았으며, O2 전화 율 또한 일반 LSCF-1928 촉매보다 Pd 코팅 LSCF-1928 촉매가 높았음을 확인하였다. An efficient Pd-coated La<sub>0.1</sub>Sr<sub>0.9</sub>Co<sub>0.2</sub>Fe<sub>0.8</sub>O<sub>3-δ</sub> (LSCF-1928) catalyst for total oxidation of methane under landfill gas at low tmeperature has been developed. Synergism was observed between Pd coating and LSCF-1928 substrate. When Pd coating on LSCF-1928, we used electroless plating method and conformed characteristic of catalyst through TPR(Temperature Programmed Reduction) analysis, XRD(X-ray Diffraction) analysis, SEM(Scanning Electron Microscope). The results demonstrated that the Pd coated LSCF-1928 catalysts showed higher performance than non-Pd LSCF-1928. Pd coated LSCF-1928 had low total oxidation temperature of methane (< 475℃) which is lower than total oxidation temperature of methane about non-Pd LSCF-1928 catalysts (= 475℃). Also, O<sub>2</sub> conversion rate was higher than non-Pd LSCF-1928 at same temperature.

      • SCOPUSKCI등재

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼